Filter Results:
(112)
Show Results For
- All HBS Web (209)
- Faculty Publications (86)
Show Results For
- All HBS Web (209)
- Faculty Publications (86)
←
Page 6 of 112
Results
Sort by
- September 2009 (Revised May 2011)
- Case
Acumen Fund: Measurement in Impact Investing (A)
By: Alnoor Ebrahim and V. Kasturi Rangan
Acumen Fund is a global venture capital firm with a dual purpose: it looks for a return on its investments, and it also seeks entrepreneurial solutions to global poverty. This case examines Acumen's new projects in Kenya. The organization's investment committee and its... View Details
Keywords: Decision Choices and Conditions; Venture Capital; Investment Return; Philanthropy and Charitable Giving; Risk Management; Corporate Social Responsibility and Impact; Business and Government Relations; Social Enterprise; Financial Services Industry; Kenya
Ebrahim, Alnoor, and V. Kasturi Rangan. "Acumen Fund: Measurement in Impact Investing (A)." Harvard Business School Case 310-011, September 2009. (Revised May 2011.)
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
get an annual budget from the provincial government but philanthropy still plays an important role in funding new programs and research and augmenting services.” The Foundation, which is one of Canada’s largest charities, provided $48.5... View Details
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Pharmaceutical Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- 16 Dec 2008
- First Look
First Look: December 16, 2008
challenge of upward voice. We first undertook in-depth exploratory research in a knowledge-intensive multinational corporation in which employee input was considered crucial. Qualitative data collected in 190 interviews with employees... View Details
Keywords: Sean Silverthorne
- 31 Jan 2012
- First Look
First Look: Jan. 31
corporate leaders have significant discretion. Corporate philanthropy is our setting to study how a differentiated structural element-the View Details
Keywords: Sean Silverthorne & Carmen Nobel
- 09 Aug 2011
- First Look
First Look: August 9
the transplant community seeks to balance quality and quantity in choosing the best matches. Financing for paired donation is a major issue, as philanthropy alone cannot support the emerging national system. We also discuss the advent of... View Details
Keywords: Sean Silverthorne
- ←
- 6